Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 29 tags : Europe save search
Prothena to Participate in JMP Securities Hematology and Oncology Summit
Published: 2021-11-29 (Crawled : 23:00) - biospace.com/
PRTA 4 | $21.03 -1.45% -1.47% 460K
|
Health Technology
|
| O: 1.31%
H: 5.14%
C: -1.16%
ema
North America and Europe Commercial Vehicles Electric Drivetrain Supplier Analysis Report 2021: Secure Development and Supply Partnerships with Traditional OEMs and New Players Provides Opportunities
Published: 2021-11-29 (Crawled : 21:00) - prnewswire.com
DAN | $11.88 0.08% 0.0% 1.7M
|
Producer Manufacturing
|
| O: -1.8%
H: 0.96%
C: -1.29%
BWA | $31.86 -1.79% 0.0% 2.5M
|
Producer Manufacturing
|
| O: -1.34%
H: 0.0%
C: 0.0%
partnership europe vehicles
EDAP to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Published: 2021-11-29 (Crawled : 16:00) - biospace.com/
EDAP | $7.47 2.33% 2.28% 13K
|
Health Technology
|
| O: -0.9%
H: 4.55%
C: 1.09%
conference
European Commission Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) as First-Line Treatment for Adult Patients With Advanced Renal Cell Carcinoma
Published: 2021-11-29 (Crawled : 13:30) - biospace.com/
MRK | $125.37 0.25% 0.1% 6.1M
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: 0.0%
keytruda treatment europe renal cell carcinoma
Bristol Myers Squibb’s Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency
Published: 2021-11-29 (Crawled : 12:30) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: -1.18%
H: 1.16%
C: 0.49%
psoriasis food treatment europe application drug plague
European Wax Center Welcomes New Board Member, Nital Scott
Published: 2021-11-29 (Crawled : 12:00) - globenewswire.com
EWCZ | $10.86 -2.86% -2.95% 350K
|
|
| O: -2.07%
H: 1.15%
C: -0.19%
europe
Masimo Rad-G® Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India
Published: 2021-11-29 (Crawled : 10:00) - biospace.com/
MASI | $136.71 -1.06% -1.08% 220K
|
Health Technology
|
| O: 0.1%
H: 2.05%
C: 0.68%
india trial
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.